P&G CFO: Consumers are dosing their products carefully

Core Insights - Proctor & Gamble (P&G) reported mixed earnings results, with second fiscal quarter sales missing estimates in key categories due to consumers opting for cheaper private label options, leading to a 1.5% decline in shares during pre-market trading [1] - Despite the sales miss, P&G beat earnings estimates and reaffirmed its full-year outlook, indicating confidence in future growth [1][7] Sales Performance - Net sales reached $22.2 billion, reflecting a 1% increase from the prior year but falling short of the $22.32 billion estimate [7] - Organic sales growth remained unchanged, compared to an estimated growth of +0.54% [7] - The beauty segment showed organic revenue growth of +4%, surpassing the +2.87% estimate, while the grooming segment reported no growth, missing the +2.42% estimate [7] - The healthcare segment achieved organic revenue growth of +3%, exceeding the +1.73% estimate, while the fabric and home care segment also reported no growth, below the +1.2% estimate [7] - The baby, feminine, and family care segment experienced a decline of -4%, worse than the -3.2% estimate [7] Margin and Earnings - Gross margin was reported at 51.2%, lower than the estimated 52.2% [7] - Adjusted earnings per share (EPS) remained unchanged at $1.88, slightly above the $1.86 estimate [7] - The full-year organic sales growth outlook was reiterated, previously set between 0% to +4%, with an estimate of +1.7% [7] - The full-year earnings per share guidance was also reiterated, ranging from $6.83 to $7.09, compared to the estimate of $6.97 [7] Market Context - Analysts have anticipated softer results for P&G, with the stock down approximately 6% over the past six months [3] - The current economic environment is characterized as a "K-shaped economy," where consumers are trading down in essential categories while trading up in discretionary beauty products [3]